References
- Cavalier E, Vasikaran S, Bhattoa HP, et al. The path to the standardization of PTH: is this a realistic possibility? a position paper of the IFCC C-BM. Clin Chim Acta. 2021;515:44–51.
- Chen H, Han X, Cui Y, et al. Parathyroid hormone fragments: new targets for the diagnosis and treatment of chronic kidney Disease-Mineral and bone disorder. Biomed Res Int. 2018;2018:9619253.
- Bringhurst FR. Circulating forms of parathyroid hormone: peeling back the onion. Clin Chem. 2003;49(12):1973–1975.
- Dupuy AM, Bargnoux AS, Morena M, et al. Moving from the second to the third generation roche PTH assays: what are the consequences for clinical practice? Clin Chem Lab Med. 2018;57(2):244–249.
- Sturgeon CM, Sprague S, Almond A, IFCC Working Group for PTH, et al. Perspective and priorities for improvement of parathyroid hormone (PTH) measurement - A view from the IFCC working group for PTH. Clin Chim Acta. 2017;467:42–47.
- Berson SA, Yalow RS, Aurbach GD, et al. Immunoassay of bovine and human parathyroid hormone. Proc Natl Acad Sci U S A. 1963;49(5):613–617.
- Nussbaum SR, Zahradnik RJ, Lavigne JR, et al. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem. 1987;33(8):1364–1367.
- John MR, Goodman WG, Gao P, et al. A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure. J Clin Endocrinol Metab. 1999;84(11):4287–4290.
- Andersen SL, Frederiksen AL, Rasmussen AB, et al. Homozygous missense variant of PTH (c.166C > T, p.(Arg56Cys)) as the cause of familial isolated hypoparathyroidism in a three-year-old child. J Pediatr Endocrinol Metab. 2022;35(5):691–694.
- Horowitz GL, Altaie S, Boyd JC, et al. EP28-A3C defining, establishing, and verifying reference intervals in the clinical laboratory; approved Guideline - Third edition. Clin Lab Stand Inst. 2010;28:1–61.
- Sai AJ, Walters RW, Fang X, et al. Relationship between vitamin D, parathyroid hormone, and bone health. J Clin Endocrinol Metab. 2011;96:436–446.
- Yalla N, Bobba G, Guo G, et al. Parathyroid hormone reference ranges in healthy individuals classified by vitamin D status. J Endocrinol Invest. 2019;42(11):1353–1360.
- Johansen MB, Christensen PA. A simple transformation independent method for outlier definition. Clin Chem Lab Med. 2018;56(9):1524–1532.
- Zhou L, Fu P. The interpretation of KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Chinese J Evidence-Based Med. 2017;17:869–875.
- Need AG, O'Loughlin PD, Morris HA, et al. The effects of age and other variables on serum parathyroid hormone in postmenopausal women attending an osteoporosis center. J Clin Endocrinol Metab. 2004;89(4):1646–1649.
- Hanon EA, Sturgeon CM, Lamb EJ. Sampling and storage conditions influencing the measurement of parathyroid hormone in blood samples: a systematic review. Clin Chem Lab Med. 2013;51(10):1925–1941.